Lorenzo Fornaro

机构：University of Pisa, Azienda Ospedaliera Universitaria Pisana · ORCID：0000-0002-0187-5904

发表论文 365 篇 · 总被引 6600 次 · h-index 36

代表论文

Durvalumab in Advanced Biliary Tract Cancer: Real‐World Data From a Large Cohort of Patients Across Multiple International Centers (2025 · Liver International · 被引 10)
Molecular profiling and matched targeted treatment in cholangiocarcinoma: Results from the Italian dataset (ANITA) (2025 · Journal of Hepatology · 被引 6)
Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor–2 Rearrangement: Results From the Phase III FIGHT-302 Trial (2026 · Journal of Clinical Oncology · 被引 2)
Pemigatinib for untreated unresectable/metastatic cholangiocarcinoma (mCCA) with fibroblast growth factor receptor-2 (FGFR2) rearrangement: Phase 3 FIGHT-302 results. (2026 · Journal of Clinical Oncology · 被引 1)
Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and Durvalumab (2026 · Targeted Oncology · 被引 1)
Outcomes of Cisplatin, Gemcitabine, and Durvalumab According to TOPAZ ‐1 Study Eligibility: A Large Global Analysis in a Real‐World Setting (2026 · International Journal of Cancer)